Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Unraveling the effect of silent, intronic and missense mutations on VWF splicing: contribution of next generation sequencing in the study of mRNA.

Borràs N, Orriols G, Batlle J, Pérez-Rodríguez A, Fidalgo T, Martinho P, López-Fernández MF, Rodríguez-Trillo Á, Lourés E, Parra R, Altisent C, Cid AR, Bonanad S, Cabrera N, Moret A, Mingot-Castellano ME, Navarro N, Pérez-Montes R, Marcellin S, Moreto A, Herrero S, Soto I, Fernández-Mosteirín N, Jiménez-Yuste V, Alonso N, de Andrés-Jacob A, Fontanes E, Campos R, Paloma MJ, Bermejo N, Berrueco R, Mateo J, Arribalzaga K, Marco P, Palomo Á, Quismondo NC, Iñigo B, Nieto MDM, Vidal R, Martínez MP, Aguinaco R, Tenorio JM, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Dobón M, Aguilar C, Vidal F, Corrales I.

Haematologica. 2019 Mar;104(3):587-598. doi: 10.3324/haematol.2018.203166. Epub 2018 Oct 25.

2.

Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project.

Pérez-Rodríguez A, Batlle J, Corrales I, Borràs N, Rodríguez-Trillo Á, Lourés E, Cid AR, Bonanad S, Cabrera N, Moret A, Parra R, Mingot-Castellano ME, Navarro N, Altisent C, Pérez-Montes R, Marcellini S, Moreto A, Herrero S, Soto I, Fernández Mosteirín N, Jiménez-Yuste V, Alonso N, de Andrés Jacob A, Fontanes E, Campos R, Paloma MJ, Bermejo N, Berrueco R, Mateo J, Arribalzaga K, Marco P, Palomo Á, Castro Quismondo N, Iñigo B, Nieto MDM, Vidal R, Martínez MP, Aguinaco R, Tenorio M, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Dobón M, Aguilar C, Batlle F, Vidal F, López-Fernández MF.

PLoS One. 2018 Jun 20;13(6):e0197876. doi: 10.1371/journal.pone.0197876. eCollection 2018.

3.

Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients.

Borràs N, Batlle J, Pérez-Rodríguez A, López-Fernández MF, Rodríguez-Trillo Á, Lourés E, Cid AR, Bonanad S, Cabrera N, Moret A, Parra R, Mingot-Castellano ME, Balda I, Altisent C, Pérez-Montes R, Fisac RM, Iruín G, Herrero S, Soto I, de Rueda B, Jiménez-Yuste V, Alonso N, Vilariño D, Arija O, Campos R, Paloma MJ, Bermejo N, Berrueco R, Mateo J, Arribalzaga K, Marco P, Palomo Á, Sarmiento L, Iñigo B, Nieto MDM, Vidal R, Martínez MP, Aguinaco R, César JM, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Cornudella R, Aguilar C, Vidal F, Corrales I.

Haematologica. 2017 Dec;102(12):2005-2014. doi: 10.3324/haematol.2017.168765. Epub 2017 Sep 29.

4.

Use of eltrombopag for secondary immune thrombocytopenia in clinical practice.

González-López TJ, Alvarez-Román MT, Pascual C, Sánchez-González B, Fernández-Fuentes F, Pérez-Rus G, Hernández-Rivas JA, Bernat S, Bastida JM, Martínez-Badas MP, Martínez-Robles V, Soto I, Olivera P, Bolaños E, Alonso R, Entrena L, Gómez-Nuñez M, Alonso A, Yera Cobo M, Caparrós I, Tenorio M, Arrieta-Cerdán E, Lopez-Ansoar E, García-Frade J, González-Porras JR.

Br J Haematol. 2017 Sep;178(6):959-970. doi: 10.1111/bjh.14788. Epub 2017 Jun 1.

PMID:
28573819
5.

Long-Term Follow-Up of a Phase II Trial of Six Cycles of Dose-Dense R-CHOP-14 for First-Line Treatment of Diffuse Large B-Cell Lymphoma in Young and Elderly Patients.

González-Barca E, Canales MA, Salar A, Ferrer S, Domingo-Domenech E, Vidal MJ, Grande C, Bargay J, Gardella S, Oriol A, Briones J, García-Frade J, Bello JL, Sánchez-Blanco JJ, Peñalver FJ, Tomás JF, Asensio A, López A, Caballero D; GELTAMO Group (Grupo Español de Linfoma y Trasplante de Médula Ósea).

Acta Haematol. 2016;136(2):76-84. doi: 10.1159/000444625. Epub 2016 May 18.

PMID:
27188649
6.

Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trial.

González-Barca E, Canales M, Salar A, Ferreiro-Martínez JJ, Ferrer-Bordes S, García-Marco JA, Sánchez-Blanco JJ, García-Frade J, Peñalver J, Bello-López JL, Sancho JM, Caballero D; GELTAMO group.

Ann Hematol. 2016 May;95(6):893-9. doi: 10.1007/s00277-016-2648-4. Epub 2016 Mar 30.

7.

Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): Proposal for a new diagnostic paradigm.

Batlle J, Pérez-Rodríguez A, Corrales I, López-Fernández MF, Rodríguez-Trillo Á, Lourés E, Cid AR, Bonanad S, Cabrera N, Moret A, Parra R, Mingot-Castellano ME, Balda I, Altisent C, Pérez-Montes R, Fisac RM, Iruín G, Herrero S, Soto I, de Rueda B, Jiménez-Yuste V, Alonso N, Vilariño D, Arija O, Campos R, Paloma MJ, Bermejo N, Toll T, Mateo J, Arribalzaga K, Marco P, Palomo Á, Sarmiento L, Iñigo B, Nieto Mdel M, Vidal R, Martínez MP, Aguinaco R, César JM, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Cornudella R, Aguilar C, Borràs N, Vidal F.

Thromb Haemost. 2016 Jan;115(1):40-50. doi: 10.1160/TH15-04-0282. Epub 2015 Aug 6.

PMID:
26245874
8.

Use of eltrombopag after romiplostim in primary immune thrombocytopenia.

González-Porras JR, Mingot-Castellano ME, Andrade MM, Alonso R, Caparrós I, Arratibel MC, Fernández-Fuertes F, Cortti MJ, Pascual C, Sánchez-González B, Bernat S, Fuertes-Palacio MA, Vázquez-Paganini JA, Olivera PE, Alvarez-Román MT, Jarque I, Cortés M, Martínez-Robles V, Díaz-Gálvez FJ, Calbacho M, Fernández-Miñano C, Garcia-Frade J, González-López TJ.

Br J Haematol. 2015 Apr;169(1):111-6. doi: 10.1111/bjh.13266. Epub 2014 Dec 18.

PMID:
25521630
9.

Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia.

González-López TJ, Pascual C, Álvarez-Román MT, Fernández-Fuertes F, Sánchez-González B, Caparrós I, Jarque I, Mingot-Castellano ME, Hernández-Rivas JA, Martín-Salces M, Solán L, Beneit P, Jiménez R, Bernat S, Andrade MM, Cortés M, Cortti MJ, Pérez-Crespo S, Gómez-Núñez M, Olivera PE, Pérez-Rus G, Martínez-Robles V, Alonso R, Fernández-Rodríguez A, Arratibel MC, Perera M, Fernández-Miñano C, Fuertes-Palacio MA, Vázquez-Paganini JA, Gutierrez-Jomarrón I, Valcarce I, de Cabo E, Sainz A, Fisac R, Aguilar C, Paz Martínez-Badas M, Peñarrubia MJ, Calbacho M, de Cos C, González-Silva M, Coria E, Alonso A, Casaus A, Luaña A, Galán P, Fernández-Canal C, Garcia-Frade J, González-Porras JR.

Am J Hematol. 2015 Mar;90(3):E40-3. doi: 10.1002/ajh.23900. Epub 2015 Jan 16.

10.

The association of food anaphylaxis in antiphospholipid syndrome and thrombosis cannot be considered a coincidence.

Armentia A, Mazón F, Pineda F, Palacios R, Crespo J, Inglada L, Martín Santos JM, García Frade J, Martín-Armentia B.

Allergol Immunopathol (Madr). 2011 Sep-Oct;39(5):314. doi: 10.1016/j.aller.2011.03.002. Epub 2011 Apr 21. No abstract available.

PMID:
21514031
11.

Food anaphylaxis in antiphospholipid syndrome and thrombosis.

Armentia A, Mazón A, Pineda F, Palacios R, Crespo J, Inglada L, Martín-Santos JM, García-Frade J, Martín-Armentia B.

Allergol Immunopathol (Madr). 2011 Jul-Aug;39(4):212-21. doi: 10.1016/j.aller.2010.06.011. Epub 2011 Jan 7.

PMID:
21216082
12.

Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study.

Lahuerta JJ, Mateos MV, Martínez-López J, Grande C, de la Rubia J, Rosiñol L, Sureda A, García-Laraña J, Díaz-Mediavilla J, Hernández-García MT, Carrera D, Besalduch J, de Arriba F, Oriol A, Escoda L, García-Frade J, Rivas-González C, Alegre A, Bladé J, San Miguel JF; Grupo Español de MM and Programa para el Estudio de la Terapéutica en Hemopatía Maligna Cooperative Study Groups.

Haematologica. 2010 Nov;95(11):1913-20. doi: 10.3324/haematol.2010.028027. Epub 2010 Jul 27.

13.

Absence of accelerated atherosclerotic disease progression after intracoronary infusion of bone marrow derived mononuclear cells in patients with acute myocardial infarction--angiographic and intravascular ultrasound--results from the TErapia Celular Aplicada al Miocardio Pilot study.

Arnold R, Villa A, Gutiérrez H, Sánchez PL, Gimeno F, Fernández ME, Gutiérrez O, Mota P, Sánchez A, García-Frade J, Fernández-Avilés F, San Román JA; TECAM (TErapia Celular Aplicada al Miocardio) research group.

Am Heart J. 2010 Jun;159(6):1154.e1-8. doi: 10.1016/j.ahj.2010.03.030.

PMID:
20569733
14.

Comparison of neointimal hyperplasia with drug-eluting stents versus bare metal stents in patients undergoing intracoronary bone-marrow mononuclear cell transplantation following acute myocardial infarction.

Villa A, Arnold R, Sánchez PL, Gimeno F, Ramos B, Cantero T, Fernández ME, Sanz R, Gutiérrez O, Mota P, García-Frade J, San Román JA, Fernández-Avilés F; Terapia Celular Aplicada al Miocardio Research Group.

Am J Cardiol. 2009 Jun 15;103(12):1651-6. doi: 10.1016/j.amjcard.2009.02.011. Epub 2009 Apr 16.

PMID:
19539071
15.

Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival.

Lahuerta JJ, Mateos MV, Martínez-López J, Rosiñol L, Sureda A, de la Rubia J, García-Laraña J, Martínez-Martínez R, Hernández-García MT, Carrera D, Besalduch J, de Arriba F, Ribera JM, Escoda L, Hernández-Ruiz B, García-Frade J, Rivas-González C, Alegre A, Bladé J, San Miguel JF.

J Clin Oncol. 2008 Dec 10;26(35):5775-82. doi: 10.1200/JCO.2008.17.9721. Epub 2008 Nov 10.

PMID:
19001321
16.

A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma.

Rosiñol L, Pérez-Simón JA, Sureda A, de la Rubia J, de Arriba F, Lahuerta JJ, González JD, Díaz-Mediavilla J, Hernández B, García-Frade J, Carrera D, León A, Hernández M, Abellán PF, Bergua JM, San Miguel J, Bladé J; Programa para el Estudio y la Terapéutica de las Hemopatías Malignas y Grupo Español de Mieloma (PETHEMA/GEM).

Blood. 2008 Nov 1;112(9):3591-3. doi: 10.1182/blood-2008-02-141598. Epub 2008 Jul 8.

17.

[Primary biliary cirrhosis, "sicca" síndrome and autoimmune hemolytic anemia].

Cantalapiedra A, Peñarrubia MJ, Gutiérrez O, García-Pajares F, Núñez H, García-Frade J, Caro-Patón A.

Rev Esp Enferm Dig. 2005 Sep;97(9):678-9. Spanish. No abstract available.

18.

Bone remodelation markers are useful in the management of monoclonal gammopathies.

Hernández JM, Suquía B, Queizan JA, Fisac RM, Sanchez JJ, Fernández-Calvo FJ, García-Sanz R, Olivier C, Bárez A, Calmuntia MJ, García-Frade J, Portero JA, López R, Aguilera C, Navajo JA, San-Miguel JF.

Hematol J. 2004;5(6):480-8.

PMID:
15570289
19.

Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction.

Fernández-Avilés F, San Román JA, García-Frade J, Fernández ME, Peñarrubia MJ, de la Fuente L, Gómez-Bueno M, Cantalapiedra A, Fernández J, Gutierrez O, Sánchez PL, Hernández C, Sanz R, García-Sancho J, Sánchez A.

Circ Res. 2004 Oct 1;95(7):742-8. Epub 2004 Sep 9.

PMID:
15358665
20.

[Intracoronary stem cell transplantation in acute myocardial infarction].

Avilés FF, San Román JA, García Frade J, Valdés M, Sánchez A, de la Fuente L, Peñarrubia MJ, Fernández ME, Tejedor P, Durán JM, Hernández C, Sanz R, García Sancho J.

Rev Esp Cardiol. 2004 Mar;57(3):201-8. Spanish.

21.

Immunophenotypic analysis of Waldenstrom's macroglobulinemia.

San Miguel JF, Vidriales MB, Ocio E, Mateo G, Sánchez-Guijo F, Sánchez ML, Escribano L, Bárez A, Moro MJ, Hernández J, Aguilera C, Cuello R, García-Frade J, López R, Portero J, Orfao A.

Semin Oncol. 2003 Apr;30(2):187-95. Erratum in: Semin Oncol. 2002 Jun;15(2):427.

PMID:
12720134
22.

Thrombin-antithrombin III complexes in the diagnosis of consumption coagulopathy.

Sureda A, García Avello A, García Frade J, Carmen Torrado MC.

Am J Hematol. 1991 Jan;36(1):74-6. No abstract available.

PMID:
2006932
23.

[Fibronectin and the ability of plasma to induce adhesion and phagocytosis in acute myeloid leukemia].

García Frade J, Burgaleta C, Alava I, Tolón R, Navarro JL, Obispo T, Herrero D.

Med Clin (Barc). 1986 Mar 22;86(11):454-6. Spanish. No abstract available.

PMID:
3458988
24.

[Plasma fibronectin and atherosclerotic processes].

García Frade J, Tolón R, García Avello A, de la Calle H, César J, Pardo A, Navarro JL.

Rev Clin Esp. 1986 Mar;178(5):226-8. Spanish. No abstract available.

PMID:
3715133
25.

[Phospholipids and platelet procoagulant activity in myeloproliferative syndromes].

Martínez E, César J, Navarro JL, Mercado A, Pardo A, García Avello A, García Frade J.

Sangre (Barc). 1985;30(1):22-7. Spanish. No abstract available.

PMID:
4039850
26.

[Homo and heterozygosity in Glanzmann's thrombasthenia].

Navarro JL, César J, Obispo T, Trejo R, Pardo A, García Avello A, García Frade J.

Sangre (Barc). 1984;29(6):1000-7. Spanish. No abstract available.

PMID:
6543477
27.

[Acquired agranulocytosis --transient or self-maintained-- with probable immune pathogenesis. Analysis of 44 cases (author's transl)].

Outeiriño J, Sánchez Fayos J, Calabuig T, Tome y Arnal MP, García Frade J, Paniagua C.

Sangre (Barc). 1979;24(5B):819-27. Spanish. No abstract available.

PMID:
524228

Supplemental Content

Loading ...
Support Center